Actrapid Penfill 5 Cartridges

Actrapid Penfill 5 Cartridges

Description:

Actrapid Penfill 5 Cartridges (Actrapid HM 100 iu/ml 5×3 ml Penfills) is a short-acting human insulin injection used for the treatment and control of diabetes mellitus. It is a prescription-only medicine designed for use with compatible insulin pens to help lower and regulate high blood glucose levels in adults and children with type 1 and type 2 diabetes. Each cartridge contains neutral human insulin produced by recombinant DNA technology, providing reliable and predictable blood sugar–lowering action when used as part of a complete diabetes management plan including diet, exercise, and regular blood glucose monitoring.

Indications:

• Indicated as an adjunct to diet and exercise to improve glycemic control in adults and children with type 1 diabetes mellitus.
• Indicated as an adjunct to diet and exercise to improve glycemic control in adults and children with type 2 diabetes mellitus when oral antidiabetic agents are insufficient or not appropriate.
• Management of hyperglycemia requiring short-acting insulin in patients with diabetes, including during acute illness, surgery, or when switching from other insulin regimens as directed by a physician.
• Helps reduce symptoms of high blood sugar such as excessive thirst, frequent urination, fatigue, blurred vision, and unintentional weight loss when used correctly.

Active Ingredients / Key Components:

• Insulin human (neutral) – 100 iu/ml (recombinant DNA origin), short-acting human insulin.
• Each 3 ml cartridge contains: 300 iu of human insulin.
• Excipients (exact quantitative composition not provided in the available data) typically include substances such as glycerol, metacresol, zinc chloride, sodium phosphate, sodium hydroxide/hydrochloric acid for pH adjustment, and water for injections. Precise concentrations are not available in the provided information.

Dosage & Administration / How to Use:

• Dosage: The dose is individual and must be determined by the treating physician based on blood glucose levels, type of diabetes, body weight, diet, physical activity, and concomitant medications. Typical total daily insulin requirements in insulin-treated patients are usually between 0.3–1.0 iu/kg/day, but this may vary widely.
• Timing: Actrapid is a short-acting insulin usually administered 30 minutes before a meal or carbohydrate-containing snack to cover post-meal blood glucose rise.
• Route of administration: Subcutaneous injection in the abdominal wall, thigh, upper arm, or buttock. Rotate injection sites within the same region to reduce the risk of lipodystrophy.
• Can be used in combination with intermediate- or long-acting insulin preparations as part of a basal–bolus regimen, according to medical advice.
• Use with pen devices:
  • Check the label to ensure you are using the correct insulin.
  • Inspect the cartridge: the solution should be clear, colorless, and free from visible particles. Do not use if cloudy, colored, or contains particles.
  • Insert the Penfill cartridge into a compatible Novo Nordisk insulin pen according to the pen’s instructions for use.
  • Attach a new sterile needle before each injection.
  • Prime the pen (usually 1–2 units) to ensure insulin flow before injecting.
  • Dial the prescribed dose and inject subcutaneously as instructed by your healthcare provider.
• With or without food: Must be injected before meals; do not skip the meal after injecting to avoid hypoglycemia.
• Missed dose: If a dose is missed, monitor blood glucose and follow your doctor’s instructions. Do not double dose to make up for a missed injection.
• Use only under medical supervision. Never change the insulin dose, type, or injection schedule without consulting your doctor.

Clinical Benefits:

• Provides effective short-acting blood glucose control around meal times in patients with type 1 and type 2 diabetes.
• Helps reduce symptoms of hyperglycemia such as excessive thirst, frequent urination, fatigue, and blurred vision when used as prescribed.
• Supports long-term diabetes management and helps lower the risk of diabetes-related complications, such as neuropathy, nephropathy, retinopathy, and cardiovascular disease, when combined with comprehensive care.
• Neutral human insulin with a well-established safety and efficacy profile, suitable for adults and children under medical supervision.
• Penfill cartridge format allows accurate dosing, convenient use with compatible insulin pens, and improved adherence to insulin therapy.

Warnings & Contraindications:

• Do not use Actrapid if you are allergic (hypersensitive) to human insulin or any of the excipients in the formulation.
• Do not use in episodes of hypoglycemia (low blood sugar). If you experience symptoms of low blood sugar, treat it first before using insulin.
• Use with extreme caution in patients with severe renal or hepatic impairment; dose adjustments may be required.
• Monitor blood glucose regularly when starting or changing insulin, or when changing diet, physical activity, or concomitant medications (e.g., oral antidiabetics, beta-blockers, corticosteroids, ACE inhibitors, diuretics).
• Beta-blockers and some other medicines may mask the symptoms of hypoglycemia; discuss all current medications with your doctor.
• Consult your doctor before use if pregnant or planning pregnancy. Insulin requirements may change during pregnancy and breastfeeding; close medical supervision is required.
• Use with caution in elderly patients and those at risk of hypoglycemia (e.g., irregular meals, strenuous exercise, alcohol intake, endocrine disorders).
• Do not inject into a vein (intravenous) unless specifically instructed and supervised by a healthcare professional.
• Do not share insulin pens or needles with anyone else to prevent cross-infection.
• Driving and operating machinery: Hypoglycemia can impair concentration and reaction time. Take precautions if you drive or operate machines, and discuss with your doctor if you experience frequent hypoglycemia.
• Consult your doctor before use if you have adrenal, pituitary, or thyroid disorders, or if you are changing from another insulin product, as dose adjustments may be needed.
• Keep out of reach of children.
• Not intended to diagnose, treat, cure, or prevent any disease beyond its approved indication for diabetes management.

Side Effects:

• Very common: Hypoglycemia (low blood sugar) – symptoms may include sweating, shakiness, palpitations, hunger, headache, dizziness, confusion, blurred vision, difficulty concentrating, and in severe cases loss of consciousness or seizures. Seek immediate medical attention for severe or prolonged hypoglycemia.
• Common: Local injection site reactions such as redness, pain, itching, swelling, or bruising. These are usually mild and transient.
• Uncommon: Lipodystrophy (thickening or thinning of the skin/fat) at injection sites if the same area is used repeatedly. Rotate injection sites to reduce this risk.
• Rare: Allergic reactions, including generalized skin rash, itching, shortness of breath, wheezing, rapid heartbeat, or swelling of the face, tongue, or throat (angioedema). These may be signs of a serious allergic reaction; seek urgent medical attention.
• Fluid retention and edema may occur, especially when improving previously poor metabolic control.
• If you notice any unusual or severe side effects, contact your doctor or pharmacist promptly.

Storage Instructions:

Store unopened Actrapid Penfill cartridges in a refrigerator at 2–8°c. Do not freeze and do not place near the freezer compartment. Keep in the outer carton to protect from light. Once in use or carried as a spare, a cartridge may generally be kept at room temperature (as per manufacturer’s leaflet; exact maximum temperature and in-use duration are not specified in the provided information and should be checked in the official package insert). Keep away from direct heat and sunlight. Do not use if the insulin has been frozen, is cloudy, colored, or contains particles. Keep container tightly closed and keep out of reach of children.

Specifications:

• Product type: Short-acting human insulin injection for subcutaneous use.
• Strength: 100 iu/ml.
• Pack size: 5 cartridges × 3 ml each (total 15 ml solution, total 1500 iu insulin).
• Form: Solution for injection in Penfill cartridges for use with compatible insulin pens.
• Intended users: Adults and children with type 1 or type 2 diabetes mellitus under medical supervision.

Disclaimer:
All pharmacy products are intended for general use only and do not replace professional medical advice, diagnosis, or treatment. Always consult a healthcare provider before use. Results may vary, and no specific outcomes are guaranteed. Products are not intended to diagnose, treat, cure, or prevent any disease unless stated. Follow label instructions carefully, as misuse may cause adverse effects. Compliance with local laws is the customer’s responsibility.